PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,300 | -13.0% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $76,200 | +35.8% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $56,100 | -52.9% | 30,000 | -35.1% | 0.00% | -50.0% |
| Q3 2022 | $119,000 | +32.2% | 46,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $90,000 | -34.8% | 46,200 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $138,000 | -11.5% | 46,200 | +33.1% | 0.01% | +25.0% |
| Q4 2021 | $156,000 | -21.2% | 34,700 | -14.7% | 0.00% | -33.3% |
| Q3 2021 | $198,000 | +1.0% | 40,700 | +42.3% | 0.01% | 0.0% |
| Q2 2021 | $196,000 | +415.8% | 28,600 | +142.4% | 0.01% | +100.0% |
| Q1 2020 | $38,000 | -50.0% | 11,800 | -37.2% | 0.00% | -50.0% |
| Q4 2019 | $76,000 | +24.6% | 18,800 | +33.3% | 0.01% | 0.0% |
| Q3 2019 | $61,000 | -12.9% | 14,100 | +8.5% | 0.01% | -33.3% |
| Q1 2019 | $70,000 | +4.5% | 13,000 | 0.0% | 0.01% | -10.0% |
| Q4 2018 | $67,000 | -42.7% | 13,000 | +8.3% | 0.01% | -28.6% |
| Q3 2018 | $117,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |